Enroll Get Info Pack
1-877-235-1997
Catherine experienced a healthy, uneventful first pregnancy until unforeseen complications arose during delivery that changed everything in an instant. Her newborn son, Cooper, was diagnosed with hypoxic ischemic encephalopathy (HIE), caused by a lack of oxygen and blood flow to his brain. This diagnosis meant Cooper may face significant challenges from the very beginning, leading his parents to explore every potential treatment avenue.

When Catherine and John were expecting their second child, Olivia, a routine appointment with Catherine’s specialist introduced a possibility the family hadn’t yet considered. The physician’s question, “Are you going to save Olivia’s stem cells?”, sparked a meaningful conversation that would open new doors for their family’s future. Catherine learned that Olivia’s cord blood could potentially be used in an experimental treatment due to Cooper’s HIE diagnosis.*

After some research and a recommendation from her OB/GYN, the family was enrolled in the Newborn Possibilities Program™ based on Cooper’s diagnosis. Olivia was born in June 2023 when Cooper was 21 months old, and to the delight of the family, the siblings were a perfect genetic match. “Having the stem cells available really gave us hope,” Catherine explained, “something we could turn to in an uncertain time.” Their story is a powerful illustration of the peace of mind that comes from being informed and prepared.

A journey toward a brighter future

On Cooper’s second birthday, he received an infusion of Olivia’s cord blood through Duke University’s Expanded Access Protocol (EAP). This EAP provides experimental cord blood infusions for eligible children with HIE and other pediatric brain injuries.1 Cooper’s participation in this protocol marked a significant step in his journey.

Catherine recalled that about nine months after the infusion, a timeline she associated with brain healing and typical childhood development, Cooper said “mama” for the first time and his speech began to develop from there. Catherine expressed her amazement at their son’s progress, “We’ll never know, but if he hadn’t gotten [the infusion] done, I really don’t think he would be doing what he is today.”

At the time of Catherine’s interview, she and John were expecting their third child, and were re-enrolled in the Newborn Possibilities Program™. The family hoped to pursue a second infusion for Cooper under Duke’s EAP using cord blood from his new sibling. Catherine reflects on her gratitude for being made aware of her newborn stem cell preservation options: “Thank goodness my specialist just mentioned it in passing, because if she hadn’t, it wouldn’t have even crossed our mind.” This story demonstrates the profound impact healthcare providers can have when they share emerging scientific knowledge, empowering families to make informed, proactive decisions.

The field of regenerative medicine is continuously advancing, and researchers are exploring how newborn stem cells can be used to address a broad number of conditions. This progress offered hope to Catherine’s family in a time of uncertainty. Preserving Olivia’s newborn stem cells provided access to an experimental treatment opportunity that aimed to improve Cooper’s quality of life.

Planning for your family’s future

This family’s experience is a heartfelt reminder of why so many parents choose to bank their baby’s newborn stem cells. It’s a valuable resource that could potentially be used for future treatments. Preserving these cells means your family has access to what could be an important medical resource that may play a critical role in meeting future health needs.

Expecting a child, or have friends or family who are? Join Cells for Life today or refer a friend When someone you refer preserves with Cells for Life, you’ll receive a cheque or storage credit to fund your storage fees. — and they’ll receive special pricing on our newborn stem cell bundle.

 

 

1. Expanded Access Protocol: Umbilical Cord Blood Infusions for Children With Brain Injuries. https://clinicaltrials.gov/study/NCT03327467. Accessed February 20, 2026.

*The use of cord blood is determined by the treating physician and is influenced by many factors, including the patient’s medical condition, the characteristics of the sample, and whether the cord blood should come from the patient or an appropriately matched donor. Cord blood has established uses in transplant medicine; however, its use in regenerative medicine is still being researched. There is no guarantee that potential medical applications being studied in the laboratory or clinical trials will become available.

‡The names in this story have been changed to protect the family’s privacy. All other details reflect their real experience. This story depicts the family’s personal experiences and is not necessarily representative of others’ experiences and cannot predict outcomes for others. Cells for Life cannot and does not guarantee specific results. Your physician or other healthcare providers should be consulted about your particular situation..

†Refer-a-Friend Program: See website for referral terms and conditions.
add chat to your website
Copy link
Powered by Social Snap